基于CRISPR-Cas的PPARGC1A激活可以增强内源性线粒体,并在心肌梗塞后改善心脏功能
Mario Escobar1, Saad A Malik2, Mira A Srinivasa3
1Department of Bioengineering, Rice University, Houston, TX 77005, USA; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA.
概括
克里斯普尔激活 (CRISPRa) 技术精确地增加PPARGC1A以促进线粒体能量生产,改善心肌梗塞 (MI) 和心力衰竭 (HF) 后的心脏功能. 这种新型的基因激活方法可以提高心脏线粒体和ATP水平.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 心脏病学 心脏病学
背景情况:
- 损坏的线粒体和不足的能量供应是心脏衰竭 (HF) 心肌梗塞 (MI) 后的心脏衰竭的关键.
- 目前的治疗方法并不能直接增强肌肉心脏的能量产生.
- 虽然PPARGC1A激活了线粒体生物发生,但超生理水平会导致不良影响.
研究的目的:
- 研究可调节的PPARGC1A表达的CRISPR激活 (CRISPRa),以增强线粒体功能.
- 在心脏病模型中评估CRISPRa介导的PPARGC1A激活的治疗潜力.
主要方法:
- 使用CRISPR激活 (CRISPRa) 技术精确控制PPARGC1A基因表达.
- 对线粒体生物发生,细胞生物能学和人类细胞和心肌细胞中的ATP生产的评估影响.
- 在急性心肌梗塞 (MI) 鼠标模型和成年人心脏中评估了体内疗效.
主要成果:
- 通过CRISPRa介导的PPARGC1A激活增加了细胞线粒体,改善了人类细胞中的线粒体功能和生物能.
- 增强人类心肌细胞的ATP生产和储备能力.
- 在体内,CRISPRa对PPARGC1A的向在心脏病发作模型中恢复了喷射分数,并在成人人心中增加了线粒体功能,包括高频率心脏病患者.
结论:
- 克里斯普拉能够调节内源PPARGC1A的激活,从而增加线粒体生物发生和功能.
- 这种方法有效地提高心脏能量生产,并改善心脏功能后MI.
- 克里斯普拉代表了一种针对心力衰竭的新型治疗策略,通过直接准心肌能量供应.
关键词:
克里斯普拉是一个.在这里,我们可以看到MI MI MI MI.它们是PGC-1α.生物能源生物能源学心肌病心脏病变的发生.基因疗法 基因疗法线粒体生物发生是线粒体生物发生.心肌梗塞的心脏病发作更多相关视频
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
7.8K
09:52Investigation of Beige Fat Biology and Metabolism Using the CRISPR SunTag-p65-HSF1 Activation System
Published on: January 6, 2023
2.9K
相关概念视频
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
02:31Homologous Recombination
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
01:59CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
01:28CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...